Mahima Datla

Director Ejecutivo en Biological E. Ltd. .

Health Technology

Finance

Perfil

Mahima Datla is currently the Managing Director & Director at Biological E.
Ltd.
and also holds the position of Director at Global Health Innovative Technology Fund.

Cargos activos de Mahima Datla

Empresas	Cargo	Inicio
Biological E. Ltd. Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India.	Director Ejecutivo	-
Global Health Innovative Technology Fund Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan.	Director/Miembro de la Junta	-

Todos los cargos activos de Mahima Datla

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mahima Datla.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Biological E. Ltd. Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India.	Health Technology
Global Health Innovative Technology Fund Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan.	Finance